Drug Interaction Report

If you are currently being treated or have been treated with leniolisib, you should let your doctor know before receiving poliovirus vaccine, inactivated, as you may have a reduced response to the vaccine. If you have recently been vaccinated with poliovirus vaccine, inactivated, your doctor may choose to postpone treatment with leniolisib. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

If you are currently being treated or have been treated with leniolisib, you should let your doctor know before receiving tetanus toxoid, as you may have a reduced response to the vaccine. If you have recently been vaccinated with tetanus toxoid, your doctor may choose to postpone treatment with leniolisib. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

If you are currently being treated or have been treated with leniolisib, you should let your doctor know before receiving diphtheria toxoid, as you may have a reduced response to the vaccine. If you have recently been vaccinated with diphtheria toxoid, your doctor may choose to postpone treatment with leniolisib. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

If you are currently being treated or have been treated with leniolisib, you should let your doctor know before receiving pertussis, acellular, as you may have a reduced response to the vaccine. If you have recently been vaccinated with pertussis, acellular, your doctor may choose to postpone treatment with leniolisib. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

If you are currently being treated or have been treated with leniolisib, you should let your doctor know before receiving hepatitis B pediatric vaccine, as you may have a reduced response to the vaccine. If you have recently been vaccinated with hepatitis B pediatric vaccine, your doctor may choose to postpone treatment with leniolisib. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Consumer information for this interaction is not currently available.

MONITOR: Coadministration with inhibitors of CYP450 3A4 including grapefruit or grapefruit juice may increase the plasma concentrations of leniolisib, which undergoes extensive CYP450 3A4-mediated first-pass metabolism in the gut wall and liver. In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands. Certain preparations of grapefruit juice (e.g., high dose, double strength) have sometimes demonstrated potent inhibition of CYP450 3A4, while other preparations (e.g., low dose, single strength) have typically demonstrated moderate inhibition. Pharmacokinetic interactions involving grapefruit juice are also subject to a high degree of interpatient variability, thus the extent to which a given patient may be affected is difficult to predict.

MANAGEMENT: Patients who regularly consume grapefruit or grapefruit juice should be monitored for adverse effects and altered plasma concentrations of leniolisib. Some authorities recommend to avoid grapefruit products during leniolisib treatment (UK).